Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

Completed · Phase 2

Conditions studied: Dupuytren's Contracture

In brief

OBJECTIVES: Evaluate the safety and efficacy of collagenase in improving flexion deformity, range of motion, and grip strength in patients with residual Dupuytren's disease.

Key facts

Study ID

NCT00004409

Run by

State University of New York

People needed

36

Starts

1995-08-01

Expected to finish

2004-04-01

Last updated by the study team

2015-03-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Stanford University Hospital — Palo Alto, California, United States
• State University of New York Health Sciences Center - Stony Brook — Stony Brook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.